Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisolone in Childhood Exogenous Allergic Alveolitis
NCT02631603Phase 2Terminated
- Start
- Apr 2015
- Primary completion
- Jul 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in hypersensitivity pneumonitis (HP) comparing Placebo with Prednisolone (2 arms). Primary endpoint: Forced Vital Capacity at 6 months. Started Apr 2015; status: terminated.
02
Drugs
prednisolone
03
Conditions
hypersensitivity pneumonitis (HP)
Beyond the preview
Go deeper on NCT02631603.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02631603.